OSI PHARMACEUTICALS, INC.

Inactive Instrument

OSI Pharmaceuticals, Inc. Stock

Equities

US6710401034

Biotechnology & Medical Research

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Press Releases: OSI Pharmaceuticals, Inc.

10-06-09	OSI PHARM : Astellas Completes Acquisition of OSI Pharmaceuticals	PR
10-06-08	OSI PHARM : Astellas Announces Successful Completion of Tender Offer for Shares of OSI	PR
10-06-04	OSI PHARM : OSI Pharmaceuticals Announces Occurrence of a Fundamental Change for Convertible Notes	BU
10-06-03	OSI PHARM : Astellas Announces Successful Completion of Initial Tender Offer for Shares of OSI and Announces Subsequent Offer Period	PR
10-05-17	OSI PHARM : Expiration Date of OSI Offer Extended to June 2, 2010	PR

More press releases

News in other languages: OSI Pharmaceuticals, Inc.

10-05-17

OSI PHARM : a reçu une offre de rachat du japonais Astellas

Other Biotechnology & Medical Research

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
	LONZA GROUP AG	+2.32%	+5.17%	-0.53%	-9.85%	45.84B
	BEONE MEDICINES AG	+1.43%	+2.03%	+27.70%	+17.42%	33.9B
	IQVIA HOLDINGS INC.	+1.91%	+2.73%	+16.14%	-12.51%	28.87B
	CELLTRION, INC.	+2.00%	+2.79%	+26.64%	+23.67%	27.52B
	REVOLUTION MEDICINES, INC.	+7.86%	+52.67%	+303.10%	+564.00%	27.01B
	REGENCELL BIOSCIENCE HOLDINGS LIMITED	-6.61%	+8.08%	+3,405.65%	+3,986.59%	15.94B
	ASCENDIS PHARMA A/S	+0.52%	+13.32%	+60.67%	+207.80%	15.36B
	MEDPACE HOLDINGS, INC.	+3.74%	+2.26%	+70.34%	+170.64%	14.31B
	EUROFINS SCIENTIFIC SE	+5.52%	+5.29%	+37.68%	+10.42%	13.37B
	Average	+2.08%	+9.32%	+438.60%	+550.91%	24.68B
	Weighted average by Cap.	+2.28%	+8.79%	+301.81%	+382.65%

See all sector performances

Company Profile

Employees

-

Sector

Biotechnology & Medical Research

More about the company

As early as today, start finding the best investment opportunities!

Optimize my profits

Optimize my profits